Aims To capture the economic and healthcare resource utilization (HCRU) burden in older
adults due to respiratory syncytial virus (RSV) infection. Methods An electronic literature …

Background Despite several studies that have estimated the economic impact of Respiratory
Syncytial Virus (RSV) in infants, limited data are available on healthcare resource use and …

Background Current estimates of the economic burden of respiratory syncytial virus (RSV)
are needed for policymakers to evaluate adult RSV vaccination strategies. Methods A cost-of …

Objective: To determine the impact of respiratory syncytial virus (RSV) infection on
healthcare resource use and costs in the US from the third-party payer perspective. Design …

Background Respiratory syncytial virus (RSV) infections are common in adults, but data
describing the cost of RSV‐associated hospitalization are lacking due to inconsistency in …

Background Respiratory syncytial virus (RSV) is a major cause of acute respiratory infection
(ARI), with high morbidity and mortality worldwide. RSV costing and burden estimates can …

BACKGROUND: Respiratory syncytial virus (RSV) is a common, contagious, and seasonal
pathogen causing 64 million acute respiratory infections annually in adults and children …

Background Respiratory syncytial virus (RSV) is increasingly recognized as an important
cause of illness in adults; however, data on RSV disease and economic burden in this age …

Background Several clinical practice guidelines exist for the management of respiratory
syncytial virus (RSV) infection, but the use and overuse of medications and medical tests …

Policymakers often rely on impact and cost-effectiveness evaluations to inform decisions
about the introduction of health interventions in low-and middle-income countries (LMICs); …